Knockdown of PROX1 in colon cancer cell lines can reduce the expression of VEGF-A and increase the expression of angiostatin, while overexpression of PROX1 can promote tumor cell angiogenesis and lymphangiogenesis, and tumor cell proliferation and migration (92). This evidence concerns the gene PLG and neoplasm.